Some ophthalmological and neurological aspects of systemic lupus erythematosus.
D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D000962:Antimalarials / Q000009:adverse effects; D002386:Cataract / Q000139:chemically induced; D004172:Diplopia / Q000150:complications; D005128:Eye Diseases / Q000150:complications*; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000097:blood / Q000150:complications*; D009157:Myasthenia Gravis / Q000150:complications; D009422:Nervous System Diseases / Q000150:complications*; D009886:Ophthalmoplegia / Q000150:complications; D010211:Papilledema / Q000150:complications; D011618:Psychotic Disorders / Q000150:complications; D012164:Retinal Diseases / Q000139:chemically induced
D000305:Adrenal Cortex Hormones; D000962:Antimalarials